Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, genetic, glycogen storage disorder characterized by polyglucosan accumulation in various tissues, manifesting with progressive proximal muscle weakness in the lower limbs and rapidly progressive, usually dilated, cardiomyopathy. Hepatic involvement and growth retardation may be associated. Early-onset immunodeficiency and autoinflammation, presenting with recurrent bacterial infections, have also been reported.
Features include always present findings: Failure to thrive; and common findings: Cholestasis, Lymphadenitis, Seizure, and Liver scarring (fibrosis) (hepatic fibrosis) and others. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Digestive system | 8 | Cholestasis, Liver scarring (fibrosis) (hepatic fibrosis), Enlarged liver (hepatomegaly) |
RBCK1 function has not been fully characterized.
Polyglucosan body myopathy 1 with or without immunodeficiency is associated with mutations in the RBCK1 gene on chromosome 20.
Genetic testing for RBCK1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 1 always present feature, 27 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
207 publications have been identified in PubMed for polyglucosan body myopathy 1 with or without immunodeficiency. Kisho has analyzed 87 by research type. Research spans Review / Meta-Analysis (55%), Epidemiology / Natural History (13%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 48 |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 2:35 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Blood and immune system |
5 |
Low red blood cell count (anemia), Recurrent bacterial infections, Enlarged spleen (splenomegaly) |
Muscles | 4 | Muscle weakness, Proximal muscle weakness, Myalgia |
Heart and blood vessels | 3 | Enlarged and weakened heart (dilated cardiomyopathy), Congestive heart failure, Heart muscle disease (cardiomyopathy) |
Skin | 3 | Eczematoid dermatitis, Nail dystrophy, Thin skin |
Lab test results | 2 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Elevated circulating hepatic transaminase concentration |
Growth and development | 2 | Failure to thrive, Growth delay |
Metabolism | 2 | Metabolic acidosis, Recurrent fever |
Bones and joints | 2 | Skeletal muscle atrophy, Sideways curvature of the spine (scoliosis) |
Brain and nerves | 1 | Seizure |
Pregnancy and birth | 1 | Neonatal omphalitis |
Eyes | 1 | Ptosis |
Disease patterns and progression | 11 | 13% |
Laboratory research | 9 | 10% |
Patient case studies | 8 | 9% |
Other research | 7 | 8% |
Clinical study results | 4 | 5% |
Lalaoui N (2026). [PMID: 41381726](https://pubmed.ncbi.nlm.nih.gov/41381726/). *Nat Rev Rheumatol*. [Review / Meta-Analysis]
Adhanom R (2025). [PMID: 40202253](https://pubmed.ncbi.nlm.nih.gov/40202253/). *J Dermatol*. [Other]
IJspeert H (2025). [PMID: 39724969](https://pubmed.ncbi.nlm.nih.gov/39724969/). *J Allergy Clin Immunol*. [Review / Meta-Analysis]
Solanich X (2025). [PMID: 41045774](https://pubmed.ncbi.nlm.nih.gov/41045774/). *Med Clin (Barc)*. [Review / Meta-Analysis]
Bazzo Catto LF (2025). [PMID: 40561208](https://pubmed.ncbi.nlm.nih.gov/40561208/). *Blood*. [Basic Science / Preclinical]
Samra S (2025). [PMID: 39369964](https://pubmed.ncbi.nlm.nih.gov/39369964/). *J Allergy Clin Immunol*. [Review / Meta-Analysis]
Nahum A (2025). [PMID: 40769319](https://pubmed.ncbi.nlm.nih.gov/40769319/). *J Allergy Clin Immunol*. [Case Report / Case Series]
Mamede L (2025). [PMID: 40599777](https://pubmed.ncbi.nlm.nih.gov/40599777/). *Front Immunol*. [Review / Meta-Analysis]
Gennery AR (2025). [PMID: 41158011](https://pubmed.ncbi.nlm.nih.gov/41158011/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]
Vasconcellos LRC (2025). [PMID: 41231985](https://pubmed.ncbi.nlm.nih.gov/41231985/). *Science*. [Basic Science / Preclinical]